Keros Therapeutics, Inc. [KROS] has reported $151.0 thousand in revenue for year ended Dec 31, 2023.
Also Read:
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $152,992,000.0 .
Also Read:
Based in Lexington, Massachusetts, Keros Therapeutics, Inc. operates in the Manufacturing sector.
Related Articles: